关注
Mary E. Rinella
Mary E. Rinella
在 bsd.uchicago.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases
N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ...
Hepatology 67 (1), 328-357, 2018
67762018
Mechanisms of NAFLD development and therapeutic strategies
SL Friedman, BA Neuschwander-Tetri, M Rinella, AJ Sanyal
Nature medicine 24 (7), 908-922, 2018
33702018
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
27462020
Nonalcoholic fatty liver disease: a systematic review
ME Rinella
Jama 313 (22), 2263-2273, 2015
26632015
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ...
Annals of Hepatology, 101133, 2023
18862023
Non-alcoholic fatty liver disease
EE Powell, VWS Wong, M Rinella
The Lancet 397 (10290), 2212-2224, 2021
17002021
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
11232019
Nonalcoholic fatty liver disease 2020: the state of the disease
TG Cotter, M Rinella
Gastroenterology 158 (7), 1851-1864, 2020
10152020
Nonalcoholic fatty liver disease
EM Brunt, VWS Wong, V Nobili, CP Day, S Sookoian, JJ Maher, ...
Nature reviews Disease primers 1 (1), 1-22, 2015
8632015
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
ME Rinella, BA Neuschwander-Tetri, MS Siddiqui, MF Abdelmalek, ...
Hepatology 77 (5), 1797-1835, 2023
7902023
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio, WT Garvey, S Kashyap, ...
Endocrine Practice 28 (5), 528-562, 2022
5762022
The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance
ME Rinella, RM Green
Journal of hepatology 40 (1), 47-51, 2004
5312004
Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet
ME Rinella, MS Elias, RR Smolak, T Fu, J Borensztajn, RM Green
Journal of lipid research 49 (5), 1068-1076, 2008
5282008
Advancing the global public health agenda for NAFLD: a consensus statement
JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ...
Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022
4992022
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
ZM Younossi, R Loomba, QM Anstee, ME Rinella, E Bugianesi, ...
Hepatology 68 (1), 349-360, 2018
4412018
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
SA Harrison, ME Rinella, MF Abdelmalek, JF Trotter, AH Paredes, ...
The Lancet 391 (10126), 1174-1185, 2018
4362018
Management of NAFLD: a stage-based approach
ME Rinella, AJ Sanyal
Nature reviews Gastroenterology & hepatology 13 (4), 196-205, 2016
4232016
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
ZM Younossi, R Loomba, ME Rinella, E Bugianesi, G Marchesini, ...
Hepatology 68 (1), 361-371, 2018
3932018
From NAFLD to MAFLD: implications of a premature change in terminology
ZM Younossi, ME Rinella, AJ Sanyal, SA Harrison, EM Brunt, Z Goodman, ...
Hepatology 73 (3), 1194-1198, 2021
3692021
Body mass index as a predictor of hepatic steatosis in living liver donors
ME Rinella, E Alonso, S Rao, P Whitington, J Fryer, M Abecassis, ...
Liver Transplantation 7 (5), 409-414, 2001
3502001
系统目前无法执行此操作,请稍后再试。
文章 1–20